CliffBio
small molecule

NORISODRINE

ISOPROTERENOL SULFATE

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameNORISODRINE
Active ingredientISOPROTERENOL SULFATE
Strength10%
Dosage formPOWDER
RouteINHALATION
ModalitySmall molecule
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

NORISODRINE patent cliff — loss of exclusivity — | CliffBio